Projects
Search from 1164 projects:
1164 Project(s)
Fibroblastendifferenzierung und -funktion im Tonsillenkarzinom
Jun 24, 2022
Fundamental Research - Jun 24, 2022 - Dec 31, 2023
Automatically Closed
Project leader: Ludewig Burkhard
Members: Meili Samuel
I6T-MC-AMAX
Jun 7, 2022A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Crohn's Disease
Clinical Studies - Jun 7, 2022 - Dec 31, 2024
Ongoing
Project leader: Brand Stephan
Members: Eckhold Annika, Krieger-Grübel Claudia, König Marius
CDED Ernährungsstudie
Jun 1, 2022The Crohn’s disease exclusion diet (CDED) for induction and maintenance of remission in Crohn’s patients with or without additional medical therapy. An open label observational trial
Clinical Studies - Jun 1, 2022 - Dec 30, 2023
Automatically Closed
Project leader: Krieger-Grübel Claudia
Members: Brand Stephan, Eckhold Annika
CED-4/CEL
Jun 1, 2022This is a double-blind, randomised, multicentre, placebo-controlled, comparative phase IIb dose-finding and efficacy trial. The trial will be conducted with four treatment groups in the form of a parallel group comparison and will serve to compare...
Clinical Studies - Jun 1, 2022 - Dec 31, 2024
Ongoing
Project leader: Brand Stephan
Members: Eckhold Annika, König Marius, Krieger-Grübel Claudia, Truniger Samuel
Retinale endotheliale Dysfunktion bei Raynaud-Phänomen
Jun 1, 2022Untersuchung der Endothelfunktion retinaler Gefässe bei Patienten mit einem Raynaud Phänomen mit dem Ziel, Veränderungen im Vergleich zu gesunden Menschen darzustellen und Beziehungen zwischen Parametern der retinalen Endothelfunktion, der Kapillarmi...
Clinical Studies - Jun 1, 2022 - Jun 30, 2025
Ongoing
Project leader: Neumann Thomas
Members: Todorova Margarita, Güsewell Sabine
SAKK 06/19 Intravesical recombinant BCG followed by perioperative chemo-immunotherapy for patients with muscleinvasive bladder cancer (MIBC).A multicenter, single-arm phase II trial
May 13, 2022Verbesserung der kurativen Therapie des muske-linvasiven Urothelkarzinoms. Durch den Einsatz von BCG lokal in der Blase und perioperativer Immuno-Chemotherapie soll die Ansprechrate verbessert werden
Clinical Studies - May 13, 2022 - Jul 26, 2030
Ongoing
SAKK 06/19 Intravesical recombinant BCG followed by perioperative chemo-immunotherapy for patients with muscleinvasive bladder cancer (MIBC).A multicenter, single-arm phase II trial
May 13, 2022Verbesserung der kurativen Therapie des muske-linvasiven Urothelkarzinoms. Durch den Einsatz von BCG lokal in der Blase und perioperativer Immuno-Chemotherapie soll die Ansprechrate verbessert werden
Clinical Studies - May 13, 2022 - Jul 26, 2030
Ongoing
SAKK 06/19 Intravesical recombinant BCG followed by perioperative chemo-immunotherapy for patients with muscleinvasive bladder cancer (MIBC).A multicenter, single-arm phase II trial
May 13, 2022Verbesserung der kurativen Therapie des muske-linvasiven Urothelkarzinoms. Durch den Einsatz von BCG lokal in der Blase und perioperativer Immuno-Chemotherapie soll die Ansprechrate verbessert werden
Clinical Studies - May 13, 2022 - Jul 26, 2030
Ongoing
Muscle-invasive bladder cancer (MIBC) and perioperative treatment
May 13, 2022Diese Studie untersucht die Kombination der Standardtherapie für das muskelinvasive Blasenkarzinom (Chemotherapie gefolgt von einer Operation mit Entfernung der Harnblase) mit einer Immuntherapie mit Bacille Calmette Guérin (BCG) und Atezolizumab. BC...
Clinical Studies - May 13, 2022 - May 13, 2032
Ongoing
Project leader: Aeppli Stefanie
Members: Scherrer Julia, Müller Fiona
Fluorescence-based rapid diagnostic tool for sensitive and selective Detection Of uReaSeproducing bacTEria causing ventilator-associated Pneumonia - DOORSTEP
May 2, 2022
Fundamental Research - May 2, 2022 - May 1, 2023
Automatically Closed
Project leader: Giovannini G
Members: Kahlert Christian, Nigg Susanne
Treatment and outcomes of surgical site infections after spinal instrumentation – a retrospective cohort study
May 2, 2022
Clinical Studies - May 2, 2022 - Dec 31, 2024
Ongoing
Project leader: Strahm Carol
Members: Cosma Tudor, Zdravkovic Vilijam
GO SOAR1 - Post-Operative Morbidity and Mortality Following Gynaecological Oncology Surgery
May 1, 2022Ziel dieser multizentrischen Studie ist es, die Versorgungsqualität und Komplikationsrate in der gynäkologischen Onkologie weltweit darzustellen. Hierfür werden die perioperativen Daten gynäkoonkologischer Patientinnen anonymisiert erfasst und die...
Healthcare Research - May 1, 2022 - Dec 31, 2023
Automatically Closed
Project leader: Gaba F, Fischer Marc
AMGEN202100057
May 1, 2022A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD). The purpose of the study is to characterize the distribution o...
Clinical Studies - May 1, 2022 - Mar 31, 2023
Completed
Project leader: Rickli Hans
Members: Vetsch Susanne, Bilz Stefan, Räss Andrea
Korrekturosteotomie des distalen Radius mit palmarer winkelstabiler Plattenosteosynthese ohne Knochengraft und ohne kortikalen Kontakt
May 1, 2022
Clinical Studies - May 1, 2022 - Dec 31, 2022
Automatically Closed
Project leader: Fuchs Johannes
Management of in-water traumatic spinal cord injury: an international practical consensus-based guideline
Apr 26, 2022
Register - Apr 26, 2022 - Dec 31, 2024
Automatically Closed
Project leader: Maschmann Christian
Members: Breindahl Niklas, Bierens Joost
Amgen Efavaleukin Alfa
Apr 25, 2022A Phase 2, Multicenter, Dose-finding, Double blinded, Pla-cebo- Controlled Study to Evaluate the Safety and Effi-cacy of Efavaleukin Alfa Induc-tion Therapy in Patients with Mederatly to Severely UC
Clinical Studies - Apr 25, 2022 - Dec 31, 2023
Automatically Closed
Project leader: Brand Stephan
Members: Eckhold Annika, Krieger-Grübel Claudia
INCMOR0208-301: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, MULTICENTER TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF TAFASITAMAB PLUS LENALIDOMIDE IN ADDITION TO RITUXIMAB VERSUS LENALIDOMIDE IN ADDITION TO RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) GRADE 1-3A OR R/R MARGINA
Apr 20, 2022Doppel-blind, Placebo-kontrollierte, randomisierte Phase 3 Studie zur Evaluation eines zusätzlichen klinischen Benefits durch die Zugabe des CD19-Antikörpers Tafasitamab zu Rituximab-Lenalidomid bei Patienten mit rezidiviertem/refraktärem Follikuläre...
Clinical Studies - Apr 20, 2022 - Dec 31, 2025
Ongoing
Project leader: Fehr Martin
Members: Bürki Ramona
MitraSwiss Register
Apr 1, 2022A longitudinal observational study of patients treated with the MitraClip system in Switzerland
Register - Apr 1, 2022 - Dec 31, 2030
Ongoing
Project leader: Haager Philipp
Members: Schneider Irene
ADDRESS
Mar 25, 2022Weight Loss and Treatment Patterns in a Real-World Population of Adults Receiving Saxenda® for Weight Management in Routine Clinical Practice in Switzerland
Clinical Studies - Mar 25, 2022 - Jun 30, 2022
Completed
Project leader: Aczel Stefan
Members: Räss Andrea
Metabotropic Glutamate Receptor 5 Imaging in Amyotrophic Lateral Sclerosis (ALS) Using Positron Emission Tomography (PET)
Mar 24, 2022Amyotrophic lateral sclerosis is a fatal neurodegenerative disorder characterized by a progressive and selective loss of upper and lower motor neurons (MNs), causing weakness and ultimately death. Glutamate excitotoxicity has been suggested to play a...
Clinical Studies - Mar 24, 2022 - Nov 30, 2025
Ongoing
Project leader: Braun Nathalie